Overview

Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the relationship between glutamate and related brain chemicals and treatment response to clozapine in patients with treatment-resistant schizophrenia.
Details
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborator:
Canadian Institutes of Health Research (CIHR)
Treatments:
Clozapine